Details for 2017177123
Up to date per 04.04.2026
Actions
Details for 2017177123
Granted/Registered
European Patent
15.11.2017 A
27.11.2019 B1
06.07.2010
US
361789 P
A61K 39/00 20060101AFI20170811BHEP
Owner
GlaxoSmithKline Biologicals S.A.Rue de l'Institut, 89 1330 RixensartBE
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
GEALL, AndrewNovartis Vaccines and Diagnostics Inc. P.O. Box 8097 Emeryville, CA 94662-8097US
RAMSAUER, KatrinNovartis Vaccines and Diagnostics Inc. P.O. Box 8097 Emeryville, CA 94662-8097US
OTTEN, GillisNovartis Vaccines and Diagnostics Inc. P.O. Box 8097 Emeryville, CA 94662-8097US
MANDL, ChristianNovartis Vaccines and Diagnostics Inc. P.O. Box 8097 Emeryville, CA 94662-8097US
Information about Fees